Description
ADU-S100 sodium salt is a synthetic cyclic dinucleotide agonist of STING.
| Product Unit Size | Cost | Quantity | Stock |
|---|
ADU-S100 sodium salt is a synthetic cyclic dinucleotide agonist of STING.
| Cas No. | 1638750-95-4 |
|---|---|
| Purity | ≥99% |
| Formula | C20H22N10O10P2S2 • 2Na |
| Formula Wt. | 734.5 |
| IUPAC Name | Disodium;(1R,6R,8R,9R,10S,15R,17R)-8,17-bis(6-aminopurin-9-yl)-3,12-dihydroxy-3,12-bis(sulfanylidene)-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecane-9,18-diol |
| Synonym | ML RR-S2 CDA Sodium Salt; STING-Inducer-1; MIW815; GTPL10192; Dithio-(Rp,Rp)-[cyclic[A(2',5')pA(3',5')p]] |
| Solubility | Soluble in water (>36.7 mg/mL, >50 mM) |
| Appearance | White crystalline powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Sivick KE, Desbien AL, Glickman LH, et al. Magnitude of therapeutic STING activation determines CD8+ cell-mediated anti-tumor immunity. Cell Rep. 2018 Dec 11;25(11):3074-3085. PMID: 30540940.
Imaging agent; Maillard reaction inhibitor.
JAK1 inhibitor.
Peptide; peptidoglycan inhibitor.
H+/K+ ATPase inhibitor.
Thienylbutyl ITC analog.
Mycotoxin produced by species of Aspergillus; D...
CDK4/6 inhibitor.
Selective inhibitor of the γ isoform of PI3K (...
PI3K and mTOR inhibitor.
Wee1 inhibitor.
Sulfonamide; dihydropteroate synthase inhibitor...
PKC and PKD activator, carcinogen.
Calcineurin inhibitor, potential TRPV1 agonist....
Calcitonin-family peptide, involved in vasodila...
Saponin found in Bupleurum, Heteromorpha, and S...
Caffeic acid ester found in Melissa, Salvia, an...
Trichothecene mycotoxin produced by Fusarium, a...
Natriuretic, vasodilatory peptide; B1/2 agonist...
GSK-3β inhibitor.
NSAID; COX-1/2 inhibitor.